Literature DB >> 4156307

A comparative study of xenobiotic-metabolizing enzymes in liver and intestine of various animal species.

R S Chhabra, R J Pohl, J R Fouts.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4156307

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  8 in total

1.  Drug-metabolizing enzyme activities in the liver and intestine of rats exposed to DDT: effects of vitamin A status.

Authors:  I de Waziers; V Azaïs
Journal:  Arch Environ Contam Toxicol       Date:  1987-05       Impact factor: 2.804

2.  Explant culture of rat colon: a model system for studying metabolism of chemical carcinogens.

Authors:  H Autrup; G D Stoner; F Jackson; C C Harris; A K Shamsuddin; L A Barrett; B F Trump
Journal:  In Vitro       Date:  1978-10

3.  Intestinal first-pass metabolism of eperisone in the rat.

Authors:  K Mihara; M Matsumura; E Yoshioka; K Hanada; H Nakasa; S Ohmori; M Kitada; H Ogata
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

4.  Concentration-dependent metabolism of diazepam in mouse liver.

Authors:  M V St-Pierre; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1995-06

5.  Formation of chlorpromazine sulphoxide and monodesmethylchlorpromazine by microsomes of small intestine.

Authors:  R Knoll; W Christ; B Müller-Oerlinghausen; H Coper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

6.  Intestinal absorption and metabolism of xenobiotics.

Authors:  R S Chhabra
Journal:  Environ Health Perspect       Date:  1979-12       Impact factor: 9.031

7.  Biotransformation of xenobiotics in human intestinal mucosa.

Authors:  H P Hoensch; R Hutt; F Hartmann
Journal:  Environ Health Perspect       Date:  1979-12       Impact factor: 9.031

8.  The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal data.

Authors:  Andrés Olivares-Morales; Oliver J D Hatley; David Turner; Aleksandra Galetin; Leon Aarons; Amin Rostami-Hodjegan
Journal:  Pharm Res       Date:  2013-09-27       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.